Tasse Daniel
Insider CIK 1502785 · RGNX Director · BLPH Director · DBVT Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RGNX REGENXBIO Inc. | A Award deriv | 2026-05-29 | 2026-06-02 | 46,600 | — | $0 | 46,600 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award | 2026-05-29 | 2026-06-02 | 9,807 | — | $0 | 28,861 | SEC↗ |
| DBVT DBV Technologies S.A. | A Award deriv | 2025-11-21 | 2025-11-24 | 964,000 | — | $0 | 964,000 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2025-05-30 | 2025-06-03 | 39,815 | — | $0 | 39,815 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award | 2025-05-30 | 2025-06-03 | 7,768 | — | $0 | 19,054 | SEC↗ |
| DBVT DBV Technologies S.A. | A Award deriv | 2024-12-04 | 2024-12-05 | 813,200 | — | $0 | 813,200 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2024-05-31 | 2024-06-04 | 24,454 | — | $0 | 24,454 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award | 2024-05-31 | 2024-06-04 | 4,790 | — | $0 | 11,286 | SEC↗ |
| DBVT DBV Technologies S.A. | P Buy | 2024-03-08 | 2024-03-11 | 17,094 | $0.83 | $14.2K | 17,094 | SEC↗ |
| DBVT DBV Technologies S.A. | A Award deriv | 2023-11-20 | 2023-11-22 | 806,672 | — | $0 | 806,672 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2023-06-02 | 2023-06-06 | 17,892 | — | $0 | 17,892 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award | 2023-06-02 | 2023-06-06 | 3,486 | — | $0 | 6,496 | SEC↗ |
| DBVT DBV Technologies S.A. | A Award deriv | 2022-11-21 | 2023-08-14 | 764,386 | — | $0 | 764,386 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2022-06-03 | 2022-06-07 | 15,324 | — | $0 | 15,324 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award | 2022-06-03 | 2022-06-07 | 3,010 | — | $0 | 3,010 | SEC↗ |
| DBVT DBV Technologies S.A. | A Award deriv | 2021-11-22 | 2021-11-24 | 274,000 | — | $0 | 274,000 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2021-06-04 | 2021-06-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2020-05-29 | 2020-06-02 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2019-05-31 | 2019-06-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award | 2018-06-21 | 2018-06-25 | 11,987 | — | $0 | 182,604 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award deriv | 2018-06-05 | 2018-06-07 | 38,216 | $2.27 | $86.8K | 58,216 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2018-05-25 | 2018-05-30 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award deriv | 2017-09-22 | 2017-09-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award | 2017-06-28 | 2017-06-30 | 25,363 | — | $0 | 170,617 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2017-05-24 | 2017-05-26 | 12,500 | — | $0 | 12,500 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2016-08-15 | 2016-08-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award deriv | 2016-06-17 | 2016-06-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award | 2016-04-28 | 2016-04-29 | 16,356 | — | $0 | 145,254 | SEC↗ |
| BLPH Bellerophon Therapeutics, | P Buy | 2015-02-19 | 2015-02-23 | 25,000 | $12.00 | $300.0K | 128,898 | SEC↗ |